ASCVD MANAGEMENT
Clinical trials for ASCVD MANAGEMENT explained in plain language.
Never miss a new study
Get alerted when new ASCVD MANAGEMENT trials appear
Sign up with your email to follow new studies for ASCVD MANAGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart drug trial targets Gene-Linked inflammation
Disease control Recruiting nowThis study tests whether the drug canakinumab can reduce inflammation in the blood vessels of people with a history of heart disease. Some participants have a specific gene change (TET2) that may increase inflammation. The study involves 120 adults and compares canakinumab to a p…
Matched conditions: ASCVD MANAGEMENT
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 05:47 UTC
-
New drug aims to melt artery plaque in heart patients
Disease control Recruiting nowThis study tests an experimental drug called ABP-745 in 200 adults with atherosclerosis (hardening of the arteries from plaque buildup). The goal is to see if it can reduce plaque in the arteries better than a placebo over 52 weeks. Participants must already be on cholesterol-low…
Matched conditions: ASCVD MANAGEMENT
Phase: PHASE2 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Disease control
Last updated May 26, 2026 05:39 UTC
-
Pharmacy helpers take on high cholesterol in heart patients
Disease control Recruiting nowThis study tests whether pharmacy staff can help people with heart disease and high cholesterol reach their LDL (bad cholesterol) goals. About 1,000 adults will get phone calls to review their medications, labs, and appointments, and their cholesterol drugs may be adjusted. The g…
Matched conditions: ASCVD MANAGEMENT
Sponsor: University of Texas at Austin • Aim: Disease control
Last updated May 07, 2026 18:43 UTC